The Dysport ™ history

Though approved in the United States in 2009, Dysport ™ has a history of use in other countries since 1991. First approved outside the U.S. for aesthetic use in 2001, Dysport ™ has steadily gained in popularity around the world. With its approval by the U.S. Food and Drug Administration, you, too may join others worldwide who have been treated with Dysport ™.  
Clinical Facts:

Three double-blind, randomized, placebo-controlled, clinical studies evaluated the efficacy of Dysport ™ for use in the temporary improvement of the appearance of moderate to severe glabellar lines. These 3 studies enrolled healthy adults (ages 19 to 75) with glabellar lines of at least moderate severity at maximum frown. Subjects were excluded if they had marked ptosis, deep dermal scarring, or a substantial inability to lessen glabellar lines, even by physically spreading them apart. The subjects in these studies received either Dysport ™ or placebo. The total dose was delivered in equally divided aliquots to specified injection sites.

What kind of improvement are you looking for?

No downtime: With Dysport ™, there is little to no downtime after injection.
Visible results: in clinical trials, the majority of patients (86% on average) had frown lines that improved form scores of “moderate” or “severe” to “none” or “mild”, respectively, as assessed at maximum frown by a physician at the 30 day evaluation, representing at least a 1 grade improvement on a 4 grade scale where0 was none and 4 was severe. A 2+ grade improvement was considered a treatment success.

Repeatable results: in clinical trials, the efficacy of Dysport ™ was demonstrated with up to 4 repeated treatments. Your results may vary. You should wait at least 90 days between treatments. The safety of Dysport ™ has not been studied for more than 12 repeated treatments.
Worldwide experience: Dysport ™ is used for aesthetic purposes in 34 countries. In the U.S. clinical trials, Dysport ™ safety was studied in more than 2,400 aesthetic patients. A total of 376 patients were studied for efficacy of the product.

Visible Improvements

Dysport ™ is a purified formulation that has been shown to deliver temporary improvements in moderate to severe frown lines, even with repeat trea™ents. So, the effect of repeat trea™ent with Dysport ™ may be comparable to your first use!
With just 1 injection into each of 5 points between and over the eyebrows, Dysport ™ stops the signal from the nerve to the muscles, ultimately resulting in a reduction of muscle activity and temporarily preventing contraction of the muscles that cause frown lines.
The untreated facial muscles still contract normally, allowing you to freely show facial expressions, such as laughing, in untreated areas.
You should not be treated with Dyport ™ more frequently than every 90 days.

What about side effects?

The most common side effects are nose and throat irritation, headache, injection site skin reaction, upper respiratory tract infection, eyelid swelling, eyelid drooping, sinus inflammation, and nausea. In some cases, Dysport ™ may cause serious side effects, such as swallowing or breathing problems, that may be life threatening. For more information on possible side effects of Dysport ™, please talk to Dr. Anil K. Gandhi 1-866-333-0310.

Language / Idioma

Need a Consultation?

Dr. Anil K. Gandhi has been practicing surgery for over 30 years. Don't wait! Se Habla Espanol


Monday - Friday
10:00 am - 6:00 pm

Saturday closed

Sunday closed